A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
Clinical trial NCT02673489 · COMPLETED
Trial details
- NCT number
- NCT02673489
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-15
- Primary completion
- 2017-03-02
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.